Task: Answer the multiple-choice question.
Query: Which compound exhibits a 17.412% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: COc1ccccc1C(=O)NNC(=O)c1ccccc1
b: CN(Cc1nc2ccccc2n1C)C(=O)c1ccco1
c: CC(C)OCCCNC(=O)c1ccccc1NC(=O)C1=CSCCO1
Answer: c. CC(C)OCCCNC(=O)c1ccccc1NC(=O)C1=CSCCO1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)OCCCNC(=O)c1ccccc1NC(=O)C1=CSCCO1
CC(C)OCCCNC(=O)c1ccccc1NC(=O)C1=CSCCO1
N-[2-(3-propan-2-yloxypropylcarbamoyl)phenyl]-3,4-dihydro-2H-1,4-oxathiine-6-carboxamide